| RETRACTED ARTICLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT R Hill, PA Madureira, B Ferreira, I Baptista, S Machado, L Colaco, ... Nature communications 8 (1), 14687, 2017 | 82 | 2017 |
| Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA-4 blockade M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ... Journal of immunology research 2016, 2016 | 33 | 2016 |
| A combined ULBP2 and SEMA5A expression signature as a prognostic and predictive biomarker for colon cancer S Demirkol, I Gomceli, M Isbilen, BE Dayanc, M Tez, EB Bostanci, ... Journal of Cancer 8 (7), 1113, 2017 | 26 | 2017 |
| Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide S Turk, C Turk, MW Akbar, B Kucukkaraduman, M Isbilen, ... PLoS One 15 (11), e0242497, 2020 | 24 | 2020 |
| A stemness and EMT based gene expression signature identifies phenotypic plasticity and is a predictive but not prognostic biomarker for breast cancer MW Akbar, M Isbilen, N Belder, SD Canli, B Kucukkaraduman, C Turk, ... Journal of Cancer 11 (4), 949, 2020 | 12 | 2020 |
| Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma KM Senses, M Gonen, AR Barutcu, Z Kalaylioglu, M Isbilen, O Konu, ... BMC Medical Genetics 14, 1-6, 2013 | 10 | 2013 |
| A novel 20-gene prognostic score in pancreatic adenocarcinoma S Demirkol Canlı, E Dedeoğlu, MW Akbar, B Küçükkaraduman, M İşbilen, ... PLoS One 15 (4), e0231835, 2020 | 8 | 2020 |
| Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma KM Senses, M Ghasemi, MW Akbar, M Isbilen, AL Fallacara, ... Medchemcomm 8 (1), 88-95, 2017 | 8 | 2017 |
| TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT. Nat Commun 8: 14687 R Hill, PA Madureira, B Ferreira, I Baptista, S Machado, L Colaço, ... | 7 | 2017 |
| Predicting chemotherapy sensitivity profiles for breast cancer cell lines with and without stem cell-like features M Isbilen, K Mert Senses, A Osmay Gure Current Signal Transduction Therapy 8 (3), 268-273, 2013 | 5 | 2013 |
| Predictive gene signature for pyrazolopyrimidine derivative c-Src inhibitor 10a sensitivity in melanoma cells B Kucukkaraduman, C Turk, AL Fallacara, M Isbilen, KM Senses, ... ACS Medicinal Chemistry Letters 11 (5), 928-932, 2020 | 4 | 2020 |
| Plasticity as an underlying mechanism of tumor heterogeneity in breast cancer MW Akbar, M Isbilen, B Kucukkaraduman, SD Canli, E Dedeoglu, ... bioRxiv, 2020.03. 11.987511, 2020 | 2 | 2020 |
| Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma H Akgun, S Metintas, G Ak, SD Canlı, M Isbilen, AO Gure, M Metintas Archives of medical science: AMS 19 (2), 355, 2023 | 1 | 2023 |
| Identification of Theranostic Gene Markers in Cancers and Prognostic Validation in Colorect Al Cancer M İşbilen PQDT-Global, 2015 | 1 | 2015 |
| Six potential biomarkers for bladder cancer: key proteins in cell-cycle division and apoptosis pathways G Inal Gültekin, Ö Timirci Kahraman, M Işbilen, S Durmuş, T Çakir, ... Journal of the Egyptian National Cancer Institute 34 (1), 54, 2022 | | 2022 |
| Investigation of Sensitivity to AZD7762 in Triple-Negative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker IM Alkac, M Işbilen, B Küçükkaraduman, AO GÜRE, B Vural Experimed 12 (2), 33-37, 2022 | | 2022 |
| Targeting breast cancer stem cells MW Akbar, M Isbilen, N Belder, S Demirkol, B Kucukkaraduman, O Sahin, ... FEBS OPEN BIO 9, 320-321, 2019 | | 2019 |
| P3. 03-039 Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy: Topic: Mesothelioma Clinical H Akgun, S Metintas, G Ak, S Demirkol, R Aydın, M Isbilen, A Gure, ... Journal of Thoracic Oncology 12 (1), S1369, 2017 | | 2017 |
| Clinical Study Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ... | | 2016 |
| Hematolojik kanserlerde moleküler hedeflere yönelik ilaç tespiti M İŞBİLEN, AO GÜRE Turkiye Klinikleri Hematology-Special Topics 7 (1), 1-7, 2014 | | 2014 |
